drugset
drugset / Trial / NCT03679481

The Effect of Tranexamic Acid on Blood Loss and Transfusion Requirements Following Open Femur Fracture Surgery

NCT03679481 ↗

Phase 4 Withdrawn The University of Texas Health Science Center, Houston
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine the effect of tranexamic acid (TXA) on blood loss and transfusion requirements in patients with femur fractures requiring open surgical approaches.

Timeline

Start
2020-04-01
Primary completion
2021-04-01
Completion
2021-04-01

Outcome

Outcome not reported

Stopped (Business): “study not started due to lack of funding”

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 1 g Intravenous

Indications

No indication recorded.